UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$463M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$360M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$345M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$265M |
| 5 |
ConocoPhillips
COP
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.03B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$293M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$239M |
| 5 |
UnitedHealth
UNH
|
+$206M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.86% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 12.1% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Communication Services | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCH
1251
DELISTED
PotlatchDeltic
PCH
| $3.77M | ﹤0.01% |
91,771
-15,664
| -15% | -$720K |
|
1252
Yeti Holdings
YETI
$3.99B
| $3.76M | ﹤0.01% |
131,981
-13,604
| -9% | -$567K |
|
1253
Belden
BDC
$5.28B
| $3.75M | ﹤0.01% |
62,452
-2,453
| -4% | -$156K |
|
1254
UMB Financial
UMBF
$11.1B
| $3.75M | ﹤0.01% |
44,469
-8,634
| -16% | -$781K |
|
|
EDR
1255
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $3.74M | ﹤0.01% |
184,754
-1,104
| -0.6% | -$25K |
|
1256
Vontier
VNT
$4.63B
| $3.72M | ﹤0.01% |
222,681
-50,059
| -18% | -$1.12M |
|
1257
Atkore
ATKR
$3.17B
| $3.71M | ﹤0.01% |
47,700
-11,913
| -20% | -$1.03M |
|
1258
10x Genomics
TXG
$7.44B
| $3.69M | ﹤0.01% |
129,513
-329,829
| -72% | -$12.6M |
|
1259
Immunocore
IMCR
$1.73B
| $3.68M | ﹤0.01% |
+78,462
| New | +$3.74M |
|
1260
SM Energy
SM
$7.55B
| $3.67M | ﹤0.01% |
97,610
-30,818
| -24% | -$1.21M |
|
|
AEL
1261
DELISTED
American Equity Investment Life Holding Company
AEL
| $3.66M | ﹤0.01% |
98,281
-11,021
| -10% | -$413K |
|
1262
Alaska Air
ALK
$5.27B
| $3.66M | ﹤0.01% |
93,417
-24,235
| -21% | -$1.06M |
|
1263
Advanced Energy
AEIS
$12.6B
| $3.66M | ﹤0.01% |
47,221
-7,730
| -14% | -$663K |
|
|
CCXI
1264
DELISTED
ChemoCentryx, Inc.
CCXI
| $3.65M | ﹤0.01% |
70,721
+768
| +1% | +$31.7K |
|
|
PACW
1265
DELISTED
PacWest Bancorp
PACW
| $3.65M | ﹤0.01% |
161,554
-43,871
| -21% | -$1.18M |
|
1266
Kymera Therapeutics
KYMR
$9.03B
| $3.65M | ﹤0.01% |
167,545
-26,779
| -14% | -$706K |
|
1267
Qfin Holdings
QFIN
$1.59B
| $3.64M | ﹤0.01% |
283,897
+38,370
| +16% | +$558K |
|
|
SGFY
1268
DELISTED
Signify Health, Inc.
SGFY
| $3.64M | ﹤0.01% |
124,832
+2,513
| +2% | +$57.9K |
|
1269
Radian Group
RDN
$4.87B
| $3.61M | ﹤0.01% |
186,909
-45,787
| -20% | -$975K |
|
1270
Cogent Communications
CCOI
$528M
| $3.6M | ﹤0.01% |
69,048
-4,088
| -6% | -$236K |
|
1271
Patterson-UTI
PTEN
$4.19B
| $3.6M | ﹤0.01% |
308,006
-70,254
| -19% | -$1M |
|
1272
Federated Hermes
FHI
$4.71B
| $3.59M | ﹤0.01% |
108,430
-27,148
| -20% | -$926K |
|
1273
BlackLine
BL
$1.7B
| $3.57M | ﹤0.01% |
59,671
-12,315
| -17% | -$826K |
|
|
CHX
1274
DELISTED
ChampionX
CHX
| $3.57M | ﹤0.01% |
182,299
-87,682
| -32% | -$1.81M |
|
1275
NewMarket
NEU
$8.37B
| $3.56M | ﹤0.01% |
11,844
-1,654
| -12% | -$496K |
|
Similar funds
UBS AM's Q3 2022 Portfolio in Review
As of Q3 2022, UBS AM held 2,816 positions worth $178B, down 6.6% from $191B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
UBS AM's Q3 2022 filing shows 65 new, 702 increased, 1,679 reduced and 77 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M. The largest sale was Apple, an estimated $2.03B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q3 2022 buy was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M.
- UBS AM added most to Accenture in Q3 2022, an estimated $463M increase.
- UBS AM's biggest Q3 2022 reduction was Apple, cutting an estimated $2.03B.
- UBS AM fully exited Vanguard Russell 1000 ETF in Q3 2022, selling an estimated $93.3M.
- UBS AM's ten largest holdings make up 21% of its $178B portfolio in Q3 2022.
- UBS AM opened 65 new positions and closed 77 in Q3 2022.
- UBS AM's portfolio value fell 6.6% quarter-over-quarter to $178B.
Based on UBS AM's 13F filing for Q3 2022, filed 14 Nov 2022.